Shares of MACOM Technology Solutions vaulted 9.8% to $280.80 on October 28 after Raymond James upgraded the stock to Outperform and slapped a $300 price target on it, betting that a recent selloff created a window for investors to buy in. MACOM Jumps 10% After Analyst Upgrade, but With Insiders Selling and the Stock Still Far From Its Peak, Is the Rally Built to Last?
Shares of MACOM Technology Solutions surged 9.8% to $280.80 on October 28, fueled by a double dose of bullish catalysts: a Wall Street upgrade and a broad semiconductor rally. The question now is whether the rebound marks a genuine inflection or a dead-cat bounce in a stock still trading 33% below its 52-week high of $418.90.
A 35% October Slide Set the Stage for the Upgrade
MACOM shares briefly plunged about 35% between October 6 and October 22 , swept up in a violent rotation out of AI-linked stocks. That dragged the stock's forward price-to-earnings ratio — a measure of how much investors pay per dollar of expected profit — from a five-year high of 66x in May to roughly 30x , below its five-year average. Raymond James analyst Melissa Fairbanks argued the sell-off was "only partly justified,"
pointing to demand across data centers, space, defense, and communications .
The Business Numbers Back the Bullish Case — For Now
Revenue in the fiscal third quarter hit $342.2 million with adjusted earnings of $1.40 per share, and the book-to-bill ratio — a measure of incoming orders versus shipments — reached a record 1.6-to-1 . Management guided fiscal Q4 revenue to $415–$425 million with adjusted gross margins of 60–61% , implying sequential growth of over 20%. Analysts expect earnings per share to jump roughly 55% in fiscal 2027 .
MACOM Isn't Flying Solo — the Whole Chip Sector Caught a Bid
The Philadelphia Semiconductor Index climbed 3.6% on October 27 , boosted by AI optimism and strong memory-chip earnings abroad. That rising tide lifted MACOM alongside peers, meaning some of the stock's momentum reflects sector sentiment rather than company-specific conviction. BMO Capital also upgraded MACOM to Outperform with a higher $335 target , and 16 of 19 analysts now rate the stock a buy or strong buy .
Insider Selling Adds a Note of Caution
Insider activity shows $355.9 million in net share sales over the past 12 months with zero purchases . That gap between Wall Street enthusiasm and boardroom behavior deserves scrutiny. The $300 target works out to about 35x fiscal 2027 earnings — reasonable for a high-growth chipmaker, but if data-center orders cool, the valuation could keep falling . Investors are effectively betting that MACOM's diversified end-markets — defense, telecom, space — can cushion any AI spending slowdown. The earnings report due shortly will test that thesis with hard numbers.